Tylenol’s current and former manufacturer intentionally withheld evidence of a link between the drug and autism, a new lawsuit alleges.
Johnson & Johnson, which for decades manufactured Tylenol, decided against warning consumers and instead promoted Tylenol as safe, including by pointing to a website called BabyCenter that it actually owned, the suit stated.
In 2022, Johnson & Johnson spun off the manufacturing unit into a new company, Kenvue.
“This was designed to shield Johnson & Johnson’s assets from claimants who successfully sue because children develop ASD and/or ADHD after their mothers ingested Tylenol during pregnancy,” Paxton said in the suit.
Oral arguments in an appeal in one of the cases are scheduled for November.
Johnson & Johnson did not respond to a request for comment regarding the litigation.
“We will vigorously defend ourselves against these claims and respond per the legal process. We stand firmly with the global medical community that acknowledges the safety of acetaminophen and believe we will continue to be successful in litigation as these claims lack legal merit and scientific support,” a spokesperson for Kenvue told The Epoch Times in an email.
“We also encourage expecting mothers to speak to their health professional before taking any over-the-counter medication, including acetaminophen, as indicated on our product label for Tylenol.”
Paxton is requesting that the court block Johnson & Johnson and Kenvue from deceptively advertising Tylenol in Texas, order the companies to destroy marketing materials that portray Tylenol as safe for pregnant women, and fine the companies $10,000 per violation of the state law prohibiting deceptive promotions.
“Additionally, seeing that the day of reckoning was coming, Johnson & Johnson attempted to escape responsibility by illegally offloading their liability onto a different company. By holding Big Pharma accountable for poisoning our people, we will help Make America Healthy Again.”









